Respiratory Institute, Cleveland Clinic.
Cleve Clin J Med. 2010 May;77(5):307-16. doi: 10.3949/ccjm.77a.09145.
In the past 2 decades, noninvasive positive pressure ventilation (NIPPV) has been increasingly used in acute respiratory failure to avoid the risks associated with intubation. It is now considered standard first-line therapy in several situations. In this review, we summarize how NIPPV has evolved, the current level of evidence that supports its use in various clinical situations, its potential contraindications, and its limitations in acute respiratory failure.
在过去的 20 年中，无创正压通气（NIPPV）已越来越多地用于急性呼吸衰竭以避免与插管相关的风险。目前，它被认为是几种情况下的标准一线治疗方法。在这篇综述中，我们总结了 NIPPV 的发展历程、支持其在各种临床情况下使用的现有证据水平、其潜在的禁忌症以及在急性呼吸衰竭中的局限性。
